793 related articles for article (PubMed ID: 34214481)
21. A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas.
Walter AW; Shearer PD; Pappo AS; Greenwald CA; Rao BN; Bowman LC; Furman WL; Gajjar A; Jenkins JJ; Pratt CB
Med Pediatr Oncol; 1998 Apr; 30(4):210-6. PubMed ID: 9473755
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy for pediatric non-rhabdomyosarcoma soft tissue sarcomas: a comprehensive review.
Kahvecioğlu A; Gültekin M; Yıldız F
Turk J Pediatr; 2023; 65(3):362-376. PubMed ID: 37395956
[TBL] [Abstract][Full Text] [Related]
23. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
[TBL] [Abstract][Full Text] [Related]
24. Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group.
Ferrari A; Chi YY; De Salvo GL; Orbach D; Brennan B; Randall RL; McCarville MB; Black JO; Alaggio R; Hawkins DS; Bisogno G; Spunt SL
Eur J Cancer; 2017 Jun; 78():1-6. PubMed ID: 28391003
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Woll PJ; Reichardt P; Le Cesne A; Bonvalot S; Azzarelli A; Hoekstra HJ; Leahy M; Van Coevorden F; Verweij J; Hogendoorn PC; Ouali M; Marreaud S; Bramwell VH; Hohenberger P;
Lancet Oncol; 2012 Oct; 13(10):1045-54. PubMed ID: 22954508
[TBL] [Abstract][Full Text] [Related]
26. New concepts for the treatment of pediatric nonrhabdomyosarcoma soft tissue sarcomas.
Ferrari A; Casanova M
Expert Rev Anticancer Ther; 2005 Apr; 5(2):307-18. PubMed ID: 15877527
[TBL] [Abstract][Full Text] [Related]
27. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Issels RD; Lindner LH; Verweij J; Wust P; Reichardt P; Schem BC; Abdel-Rahman S; Daugaard S; Salat C; Wendtner CM; Vujaskovic Z; Wessalowski R; Jauch KW; Dürr HR; Ploner F; Baur-Melnyk A; Mansmann U; Hiddemann W; Blay JY; Hohenberger P; ;
Lancet Oncol; 2010 Jun; 11(6):561-70. PubMed ID: 20434400
[TBL] [Abstract][Full Text] [Related]
28. Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study).
Chisholm JC; Merks JHM; Casanova M; Bisogno G; Orbach D; Gentet JC; Thomassin-Defachelles AS; Chastagner P; Lowis S; Ronghe M; McHugh K; van Rijn RR; Hilton M; Bachir J; Fürst-Recktenwald S; Geoerger B; Oberlin O;
Eur J Cancer; 2017 Sep; 83():177-184. PubMed ID: 28738258
[TBL] [Abstract][Full Text] [Related]
29. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.
Davis EJ; Chugh R; Zhao L; Lucas DR; Biermann JS; Zalupski MM; Feng M; Wong SL; Jacobson J; Zyczynski L; Reinke D; Metko G; Baker LH; Schuetze SM
Eur J Cancer; 2015 Sep; 51(13):1794-802. PubMed ID: 26066736
[TBL] [Abstract][Full Text] [Related]
30. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
31. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
Gortzak E; Azzarelli A; Buesa J; Bramwell VH; van Coevorden F; van Geel AN; Ezzat A; Santoro A; Oosterhuis JW; van Glabbeke M; Kirkpatrick A; Verweij J;
Eur J Cancer; 2001 Jun; 37(9):1096-103. PubMed ID: 11378339
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.
DeLaney TF; Spiro IJ; Suit HD; Gebhardt MC; Hornicek FJ; Mankin HJ; Rosenberg AL; Rosenthal DI; Miryousefi F; Ancukiewicz M; Harmon DC
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1117-27. PubMed ID: 12829150
[TBL] [Abstract][Full Text] [Related]
33. Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).
Brennan B; Zanetti I; De Salvo GL; Orbach D; Gallego S; Francotte N; Schifflers S; Van Noesel M; Kelsey A; Casanova M; Dagrada GP; Collini P; Zin A; Santoro L; Ferrari A
Pediatr Blood Cancer; 2020 Oct; 67(10):e28351. PubMed ID: 32558231
[TBL] [Abstract][Full Text] [Related]
34. Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).
Tanaka K; Mizusawa J; Fukuda H; Araki N; Chuman H; Takahashi M; Ozaki T; Hiruma T; Tsuchiya H; Morioka H; Hatano H; Iwamoto Y
Jpn J Clin Oncol; 2015 Jun; 45(6):555-61. PubMed ID: 25838293
[TBL] [Abstract][Full Text] [Related]
35. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.
Tanaka K; Mizusawa J; Naka N; Kawai A; Katagiri H; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Watanuki M; Yoshida Y; Okamoto T; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Ae K; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y
BMC Cancer; 2019 Sep; 19(1):890. PubMed ID: 31492159
[TBL] [Abstract][Full Text] [Related]
36. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
37. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
[TBL] [Abstract][Full Text] [Related]
38. Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas.
Ryan CW; Montag AG; Hosenpud JR; Samuels B; Hayden JB; Hung AY; Mansoor A; Peabody TD; Mundt AJ; Undevia S
Cancer; 2008 Jun; 112(11):2432-9. PubMed ID: 18348295
[TBL] [Abstract][Full Text] [Related]
39. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
Schmitt T; Lehner B; Kasper B; Bischof M; Roeder F; Dietrich S; Dimitrakopoulou-Strauss A; Strauss LG; Mechtersheimer G; Wuchter P; Ho AD; Egerer G
BMC Cancer; 2011 Dec; 11():510. PubMed ID: 22152120
[TBL] [Abstract][Full Text] [Related]
40. The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series.
Orbach D; Brennan B; Bisogno G; Van Noesel M; Minard-Colin V; Daragjati J; Casanova M; Corradini N; Zanetti I; De Salvo GL; Defachelles AS; Kelsey A; Arush MB; Francotte N; Ferrari A
Lancet Child Adolesc Health; 2017 Dec; 1(4):284-292. PubMed ID: 30169184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
